Literature DB >> 7549465

Gene expression as a target for new drug discovery.

A Heguy1, A A Stewart, J D Haley, D E Smith, J G Foulkes.   

Abstract

Over the last 7 years we have carried out a major research effort focused on gene transcription as a novel approach to drug discovery. The goal is to identify small molecular weight compounds that modulate the expression of a target gene in a specific manner, thereby either increasing or decreasing the concentration of the corresponding protein product. Transcriptional modulation not only provides a potential means to replace recombinant proteins as drugs, but also provides a novel approach to manipulate key gene targets in many therapeutic areas. This article describes some of the features and advantages of transcription-based pharmaceuticals and illustrates how this approach can be applied to drug discovery with a program we are pursuing to identify new treatments for sickle cell disease and beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549465      PMCID: PMC6134365     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  30 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

2.  A dominant control region from the human beta-globin locus conferring integration site-independent gene expression.

Authors:  D Talbot; P Collis; M Antoniou; M Vidal; F Grosveld; D R Greaves
Journal:  Nature       Date:  1989-03-23       Impact factor: 49.962

3.  The "beta-like-globin" gene domain in human erythroid cells.

Authors:  D Tuan; W Solomon; Q Li; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 4.  Molecular physiology and genetics of NIDDM. Importance of metabolic staging.

Authors:  D K Granner; R M O'Brien
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

Review 5.  Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos; A W Nienhuis
Journal:  Annu Rev Med       Date:  1992       Impact factor: 13.739

6.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

7.  Hormonal chemoprevention of cancer in women.

Authors:  B E Henderson; R K Ross; M C Pike
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

8.  Specific expression of a foreign beta-globin gene in erythroid cells of transgenic mice.

Authors:  K Chada; J Magram; K Raphael; G Radice; E Lacy; F Costantini
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

Authors:  F Grosveld; G B van Assendelft; D R Greaves; G Kollias
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

10.  Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.

Authors:  S M Jane; P A Ney; E F Vanin; D L Gumucio; A W Nienhuis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  7 in total

1.  Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases.

Authors:  W S Blair; T B Parsley; H P Bogerd; J S Towner; B L Semler; B R Cullen
Journal:  RNA       Date:  1998-02       Impact factor: 4.942

2.  The critical role of p38 MAP kinase in T cell HIV-1 replication.

Authors:  P S Cohen; H Schmidtmayerova; J Dennis; L Dubrovsky; B Sherry; H Wang; M Bukrinsky; K J Tracey
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

Review 3.  Transcription factor AP-2 and monoaminergic functions in the central nervous system.

Authors:  M Damberg
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.

Authors:  Cecilia Berggard; Mattias Damberg; Lars Oreland
Journal:  BMC Pharmacol       Date:  2005-01-21

5.  DESE: estimating driver tissues by selective expression of genes associated with complex diseases or traits.

Authors:  Lin Jiang; Chao Xue; Sheng Dai; Shangzhen Chen; Peikai Chen; Pak Chung Sham; Haijun Wang; Miaoxin Li
Journal:  Genome Biol       Date:  2019-11-06       Impact factor: 13.583

6.  Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.

Authors:  Yunxia Wang; Song Zhang; Fengcheng Li; Ying Zhou; Ying Zhang; Zhengwen Wang; Runyuan Zhang; Jiang Zhu; Yuxiang Ren; Ying Tan; Chu Qin; Yinghong Li; Xiaoxu Li; Yuzong Chen; Feng Zhu
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

7.  Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells.

Authors:  Shahinda S R Alsayed; Shichun Lun; Anders W Bailey; Amreena Suri; Chiang-Ching Huang; Mauro Mocerino; Alan Payne; Simone Treiger Sredni; William R Bishai; Hendra Gunosewoyo
Journal:  RSC Adv       Date:  2021-04-26       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.